BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27939885)

  • 1. Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons.
    Takamatsu G; Katagiri C; Tomoyuki T; Shimizu-Okabe C; Nakamura W; Nakamura-Higa M; Hayakawa T; Wakabayashi S; Kondo T; Takayama C; Matsushita M
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1327-1333. PubMed ID: 27939885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene.
    Tomioka T; Maruoka H; Kawa H; Yamazoe R; Fujiki D; Shimoke K; Ikeuchi T
    Neurosci Res; 2014 Nov; 88():39-48. PubMed ID: 25128386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxamate-based histone deacetylase inhibitors can protect neurons from oxidative stress via a histone deacetylase-independent catalase-like mechanism.
    Olson DE; Sleiman SF; Bourassa MW; Wagner FF; Gale JP; Zhang YL; Ratan RR; Holson EB
    Chem Biol; 2015 Apr; 22(4):439-445. PubMed ID: 25892200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
    Koppel I; Timmusk T
    Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.
    Schroeder FA; Lewis MC; Fass DM; Wagner FF; Zhang YL; Hennig KM; Gale J; Zhao WN; Reis S; Barker DD; Berry-Scott E; Kim SW; Clore EL; Hooker JM; Holson EB; Haggarty SJ; Petryshen TL
    PLoS One; 2013; 8(8):e71323. PubMed ID: 23967191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal Exposure to Histone Deacetylase Inhibitors Affects Gene Expression of Autism-Related Molecules and Delays Neuronal Maturation.
    Kawanai T; Ago Y; Watanabe R; Inoue A; Taruta A; Onaka Y; Hasebe S; Hashimoto H; Matsuda T; Takuma K
    Neurochem Res; 2016 Oct; 41(10):2574-2584. PubMed ID: 27300699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.
    Glaser KB; Staver MJ; Waring JF; Stender J; Ulrich RG; Davidsen SK
    Mol Cancer Ther; 2003 Feb; 2(2):151-63. PubMed ID: 12589032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons.
    Tian F; Marini AM; Lipsky RH
    Ann N Y Acad Sci; 2010 Jun; 1199():186-93. PubMed ID: 20633124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory.
    Zhao WN; Ghosh B; Tyler M; Lalonde J; Joseph NF; Kosaric N; Fass DM; Tsai LH; Mazitschek R; Haggarty SJ
    ACS Chem Neurosci; 2018 Sep; 9(9):2262-2273. PubMed ID: 29932631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue.
    Rumbaugh G; Sillivan SE; Ozkan ED; Rojas CS; Hubbs CR; Aceti M; Kilgore M; Kudugunti S; Puthanveettil SV; Sweatt JD; Rusche J; Miller CA
    Neuropsychopharmacology; 2015 Sep; 40(10):2307-16. PubMed ID: 25837283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
    Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke.
    Tang Y; Lin YH; Ni HY; Dong J; Yuan HJ; Zhang Y; Liang HY; Yao MC; Zhou QG; Wu HY; Chang L; Luo CX; Zhu DY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
    Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
    J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.
    Busbee PB; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):7-16. PubMed ID: 24200994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
    Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors.
    Halsall J; Gupta V; O'Neill LP; Turner BM; Nightingale KP
    PLoS One; 2012; 7(3):e33453. PubMed ID: 22479401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition.
    Sleiman SF; Olson DE; Bourassa MW; Karuppagounder SS; Zhang YL; Gale J; Wagner FF; Basso M; Coppola G; Pinto JT; Holson EB; Ratan RR
    J Neurosci; 2014 Oct; 34(43):14328-37. PubMed ID: 25339746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.
    Fessler EB; Chibane FL; Wang Z; Chuang DM
    Curr Pharm Des; 2013; 19(28):5105-20. PubMed ID: 23448466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.